UnitedHealth (UNH) has won a favorable finding in a lawsuit in which the DOJ claimed the company overbilled Medicare by at least $2.1B, with a special master overseeing the collection of evidence recommending to a federal judge that the DOJ is “lacking any evidence” to support its claims, the analyst tells investors in a research note. The judge will not decide whether to adopt the recommendation, according to the report. Shares of UnitedHealth are up 2% to $476.32 in late morning trading.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Dow Jones Dips Alongside Economic Data
- DOJ investigating use of Semler Scientific’s QuantaFlo, STAT reports
- UnitedHealth price target lowered to $595 from $645 at Stephens
- Home Depot upgraded, Flywire downgraded: Wall Street’s top analyst calls
- UnitedHealth downgraded to Hold from Buy at Erste Group